Important Information

AMP 2013 Annual Meeting
November 14-16, 2013
Phoenix Convention Center
Phoenix, AZ
Corporate Workshop Day
November 13, 2013
Visit Meeting Page

AMP 2013 MGP Review Course
April 4-7, 2013
Double Tree by Hilton Hotel
Bethesda - Washington DC
Visit Course Page

Special Features

AMP International
AMP Test Directory
Awards, Grants & Honors
Career Development
Membership Information
Online Member Directory
The Journal of Molecular Diagnostics
Trainee Programs
Web Library

How to Help

Corporate Support Opportunities
Donate to AMP
Volunteer

Clinical Practice Committee Working Groups

clinical practice committee

Clinical Practice Committee - Infectious Disease Working Group

The current focus for the Infectious Diseases Division of the Clinical Practice Committee is to work towards the normalization of quantitative nucleic acid amplification testing for analytes such as cytomegalovirus (CMV), Epstein-Barr virus (EBV) and BK virus, beginning with CMV.

CMV Working Group

The CMV Working Group is comprised of 64 AMP members with a uniform interest in standardizing CMV quantitation by PCR. This group was formed in the fall of 2003 under the leadership of Dr. Daynna Wolff. In 2004, Dr. Wolff, with the assistance of Dr. Paul Neuwald, coordinated a multicenter analysis which demonstrated that laboratories across the country using a wide variety of platforms performed similarly in terms of relative quantification from sample to sample. However, there was disparity in terms of absolute value.Â The results of this project were presented at the 2004 Annual Meeting and are available in the AMP Web Library. The current focus of the group is to work with the National Institutes of Standards and Technologies (NIST) for the formation of a standard unit for CMV PCR, to which all labs can normalize their system.

For more information, contact: Kathleen Stellrecht, PhD